A detailed history of New York State Common Retirement Fund transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 46,445 shares of MDGL stock, worth $10.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,445
Previous 51,173 9.24%
Holding current value
$10.1 Million
Previous $14.3 Million 31.25%
% of portfolio
0.01%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$212.22 - $292.96 $1 Million - $1.39 Million
-4,728 Reduced 9.24%
46,445 $9.86 Million
Q2 2024

Jul 31, 2024

BUY
$193.33 - $291.99 $5.56 Million - $8.4 Million
28,774 Added 128.46%
51,173 $14.3 Million
Q1 2024

May 07, 2024

BUY
$171.37 - $283.23 $694,391 - $1.15 Million
4,052 Added 22.09%
22,399 $5.98 Million
Q4 2023

Feb 01, 2024

BUY
$120.4 - $237.13 $211,061 - $415,688
1,753 Added 10.56%
18,347 $4.25 Million
Q3 2023

Nov 07, 2023

BUY
$146.04 - $225.78 $291,203 - $450,205
1,994 Added 13.66%
16,594 $2.42 Million
Q2 2023

Aug 07, 2023

SELL
$203.88 - $312.0 $591,659 - $905,424
-2,902 Reduced 16.58%
14,600 $3.37 Million
Q1 2023

May 02, 2023

SELL
$231.06 - $307.08 $949,887 - $1.26 Million
-4,111 Reduced 19.02%
17,502 $4.24 Million
Q4 2022

Jan 30, 2023

BUY
$58.39 - $296.54 $234,961 - $1.19 Million
4,024 Added 22.88%
21,613 $6.27 Million
Q3 2022

Nov 08, 2022

BUY
$60.57 - $79.51 $2,180 - $2,862
36 Added 0.21%
17,589 $1.14 Million
Q2 2022

Aug 04, 2022

BUY
$58.04 - $100.2 $530,891 - $916,529
9,147 Added 108.82%
17,553 $1.26 Million
Q1 2022

May 05, 2022

BUY
$55.89 - $101.89 $11,736 - $21,396
210 Added 2.56%
8,406 $825,000
Q4 2021

Feb 02, 2022

SELL
$72.34 - $95.09 $1,591 - $2,091
-22 Reduced 0.27%
8,196 $695,000
Q3 2021

Nov 02, 2021

SELL
$78.35 - $105.02 $129,512 - $173,598
-1,653 Reduced 16.75%
8,218 $656,000
Q2 2021

Aug 02, 2021

BUY
$97.2 - $137.59 $172,141 - $243,671
1,771 Added 21.86%
9,871 $962,000
Q2 2020

Aug 07, 2020

BUY
$60.13 - $125.71 $18,039 - $37,713
300 Added 3.85%
8,100 $917,000
Q4 2019

Feb 05, 2020

SELL
$84.28 - $118.5 $109,564 - $154,050
-1,300 Reduced 14.29%
7,800 $711,000
Q3 2019

Nov 07, 2019

BUY
$84.4 - $106.53 $84,400 - $106,530
1,000 Added 12.35%
9,100 $785,000
Q2 2019

Aug 09, 2019

BUY
$91.13 - $142.5 $91,130 - $142,500
1,000 Added 14.08%
8,100 $849,000
Q4 2018

Feb 08, 2019

SELL
$94.77 - $215.54 $56,862 - $129,324
-600 Reduced 7.79%
7,100 $800,000
Q3 2018

Nov 07, 2018

BUY
$207.3 - $300.31 $248,760 - $360,372
1,200 Added 18.46%
7,700 $1.65 Million
Q2 2018

Aug 10, 2018

BUY
$101.55 - $313.9 $203,100 - $627,800
2,000 Added 44.44%
6,500 $1.82 Million
Q4 2017

Feb 13, 2018

SELL
$39.35 - $97.37 $86,570 - $214,214
-2,200 Reduced 32.84%
4,500 $413,000
Q2 2017

Aug 11, 2017

BUY
N/A
6,700
6,700 $109,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.72B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.